C12Y 406/01
Phosphorus-oxygen lyases
Official title: Phosphorus-oxygen lyases (4.6.1)
C12Y406/01 (Phosphorus-oxygen lyases) appears on 93 US grants and 166 published applications in this corpus.
Search patents in C12Y- Granted patents
- 93
- Published applications
- 166
- Assignees
- 103
- Inventors
- 342
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 4 |
| 2004 | 0 | 6 |
| 2005 | 0 | 5 |
| 2006 | 0 | 1 |
| 2007 | 2 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 2 | 0 |
| 2012 | 0 | 3 |
| 2013 | 0 | 9 |
| 2014 | 3 | 5 |
| 2015 | 10 | 12 |
| 2016 | 10 | 13 |
| 2017 | 8 | 15 |
| 2018 | 11 | 8 |
| 2019 | 7 | 9 |
| 2020 | 6 | 10 |
| 2021 | 9 | 11 |
| 2022 | 3 | 10 |
| 2023 | 4 | 8 |
| 2024 | 9 | 10 |
| 2025 | 3 | 10 |
| 2026 | 1 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 406/01001Aodenylate cyclase43
- C12Y 406/01002Guanylate cyclase31
- C12Y 406/010122-c-methyl-d-erythritol 2,4-cyclodiphosphate synthase3
- C12Y 406/01013Phosphatidylinositol diacylglycerol-lyase2
- C12Y 406/01015Fad-amp lyase2
- C12Y 406/01006Cytidylate cyclase0
- C12Y 406/01014Glycosylphosphatidylinositol diacylglycerol-lyase0
Recent patents
- Methods of engineering platelets for targeting circulating tumor cells5 May 2026US 12,618,076 B2University of Utah Research Foundation
- Photoactivated adenylyl cyclase30 Dec 2025US 12,509,674 B2Hamamatsu Photonics K.K.
- Microbial fermentation for the production of terpenes29 Apr 2025US 12,286,660 B2LanzaTech, Inc.
- CBLB endonuclease variants, compositions, and methods of use18 Feb 2025US 12,227,740 B2Regeneron Pharmaceuticals, Inc.
- Guide RNA that targets a mutant human guanylate cyclase 2A allele17 Dec 2024US 12,168,062 B2EmendoBio Inc.
- Methods and system for optogenetic stimulation of adipocytes24 Sep 2026US 2026/0284229 A1MaineHealth
- Hybrid soybean20 Aug 2026US 2026/0242818 A1Cornell University
- Gucy2c t cell-antigen couplers and uses thereof4 Jun 2026US 2026/0151483 A1Triumvira Immunologics USA, Inc.
- Humanized gucy2c t cell-antigen couplers and uses thereof21 May 2026US 2026/0137784 A1Triumvira Immunologics USA, Inc.
- Methods of inducing site-specific cleavage of rna polynucleotides with t2 family ribonucleases12 Mar 2026US 2026/0071268 A1Waters Technologies Corporation
Most cited
By later US patents
- Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated39US 5,324,731 AAmira, Inc. · 1994
- Minimally-invasive measurement of esophageal inflammation34US 8,637,239 B2The Board of Trustees of the University of Illinois · 2014
- Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent24US 5,676,978 AAmira, Inc. · 1997
- Creatine analogs having antiviral activity22US 5,321,030 AAmira, Inc. · 1994
- Host cells with artificial endosymbionts19US 8,956,873 B2Bell Biosystems, Inc. · 2015